Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Public ClinicalTrials.gov record NCT00099320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to compare the effects of twice-daily exenatide plus oral antidiabetic (OAD) agents and twice-daily placebo plus OAD with respect to glycemic control, as measured by hemoglobin A1c (HbA1c), in patients with type 2 diabetes who experience inadequate glycemic control with OAD alone.
Study identification
- NCT ID
- NCT00099320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 182 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2004
- Primary completion
- Jul 31, 2005
- Completion
- Jul 31, 2005
- Last update posted
- Feb 22, 2015
2004 – 2005
United States locations
- U.S. sites
- 40
- U.S. states
- 21
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | La Jolla | California | — | — |
| Research Site | San Mateo | California | — | — |
| Research Site | Santa Barbara | California | — | — |
| Research Site | Spring Valley | California | — | — |
| Research Site | Hialeah | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Melbourne | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Idaho Falls | Idaho | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Baton Rouge | Louisiana | — | — |
| Research Site | Kalamazoo | Michigan | — | — |
| Research Site | Troy | Michigan | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | McCook | Nebraska | — | — |
| Research Site | North Platte | Nebraska | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Scottsbluff | Nebraska | — | — |
| Research Site | Princeton | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Greenville | North Carolina | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Chattanooga | Tennessee | — | — |
| Research Site | Knoxville | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Georgetown | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | The Colony | Texas | — | — |
| Research Site | Olympia | Washington | — | — |
| Research Site | Renton | Washington | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Charleston | West Virginia | — | — |
| Research Site | Huntington | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
Recently updated Type 2 Diabetes Mellitus trials
Other public records listing Type 2 Diabetes Mellitus. Sorted by last update posted; newest first. Not a recommendation.
- NCT07743450: A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes Recruiting
- NCT07662044: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus Recruiting
- NCT07521475: Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes Recruiting
- NCT07662135: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin Recruiting
- NCT07662109: A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus Recruiting
- NCT07662213: A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00099320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2015 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00099320 live on ClinicalTrials.gov.